Such an implementation could be investigated with anti-CD40 as an immunoadjuvant, thereby extending the use of radiotherapy to treatment of both local and advanced/metastatic cancer, with curative intent leveraging the abscopal effect. This evidence concerns the gene CD40 and metastatic malignant neoplasm.